ITCI logo

Intra-Cellular Therapies (ITCI) Price To Sales Ratio

PS Ratio

20.51
0.000.00%

7 min ago


Summary


Performance

ITCI PS Ratio Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherITCIvaluationmetrics:

PS Ratio Formula

P/S =  
Market capitalization
TTM Revenue

ITCI PS Ratio Trends

PeriodPeriodPS ratioPS ratioPricePriceMarket capMarket capTTM revenueTTM revenue
todaytoday0.0%-0.0%-0.0%+11.1%
1 m1 month+3.0%+3.0%+3.0%-
3 m3 months+60.5%+60.0%+60.5%0.0%
6 m6 months+45.4%+74.5%+75.6%-
ytdytd+57.4%+57.2%+57.4%-
1 y1 year+53.5%+105.7%+126.0%0.0%
5 y5 years-+719.3%+1217.2%+62.8%

ITCI PS Ratio Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-0.1%19.84+3.4%
3 m3-month20.52-0.1%12.73+61.1%
6 m6-month20.52-0.1%12.26+67.3%
1 y1-year20.52-0.1%10.05+104.1%
3 y3-year71.12-71.2%10.05+104.1%
5 y5-year2005.94-99.0%10.05+104.1%
alltimeall time76.36 K-100.0%10.05+104.1%

Intra-Cellular Therapies PS Ratio History

DateValue
2025
20.51(+57.4%)
2024
13.03(-13.2%)
2023
15.01(-25.5%)
2022
20.14(-61.6%)
2021
52.45(-53.8%)
DateValue
2020
113.56(-96.5%)
2017
3215.03(+62.7%)
2016
1975.48(-97.4%)
2015
75.61 K(+7851.2%)
2014
950.98

FAQ

  • What is Intra-Cellular Therapies price to sales ratio?
  • What is the all time high PS ratio for Intra-Cellular Therapies?
  • What is ITCI price to sales ratio year-to-date change?
  • What is Intra-Cellular Therapies PS ratio year-on-year change?

What is Intra-Cellular Therapies price to sales ratio?

The current PS ratio of ITCI is 20.51

What is the all time high PS ratio for Intra-Cellular Therapies?

Intra-Cellular Therapies all-time high price to sales ratio is 76.36 K

What is ITCI price to sales ratio year-to-date change?

Intra-Cellular Therapies price to sales ratio has changed by +7.48 (+57.41%) since the beginning of the year

What is Intra-Cellular Therapies PS ratio year-on-year change?

Over the past year, ITCI price to sales ratio has changed by +7.15 (+53.52%)